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A b s t r a c t
Background and aim: Several studies have reported that elevated red cell distribution width (RDW) is associated with poor 
outcomes in patients with coronary artery disease, chronic heart failure and aortic stenosis following transcatheter aortic valve 
replacement. Their prognostic utility in patients undergoing aortic valve replacement (AVR) surgery is unknown.  
Methods: We prospectively evaluated the prognostic value of RDW in a group of 191 consecutive patients with severe 
symptomatic aortic stenosis undergoing AVR. The pre-defined primary endpoint at the 30-day follow-up was composed of: 
all cause mortality, perioperative myocardial infarction, perioperative renal failure, prolonged mechanical ventilation, stroke, 
heart failure, successfully resuscitated cardiac arrest, the occurrence of multiple-organ failure, and the need for additional 
surgery for any reason. The secondary endpoint was total mortality.
Results: The composite endpoint occurred in 54 patients. In univariate analysis RDW (p < 0.0001), haemoglobin level 
(p = 0.005), haematocrit (p = 0.01), red blood cell count (RBC; p = 0.002), glomerular filtration rate (p = 0.003), New York 
Heart Association classification (p = 0.02), atrial fibrillation (p = 0.0044), and pulmonary blood pressure (p = 0.004) were 
associated with the occurrence of the composite endpoint. RDW (p = 0.0005), haemoglobin level (p = 0.004), haematocrit 
(p = 0.004), RBC (p = 0.0009) and mean corpuscular volume (p = 0.01) were associated with an increased risk of death. 
In multivariate analysis, RDW (OR 3.274; 95% CI 1.285–8.344; p = 0.0003) and RBC (OR 0.373; 95% CI 0.176–0.787; 
p = 0.0097) remained independent predictors of the composite endpoint. Receiver operating characteristic analysis deter-
mined a cut-off value of RDW for the prediction of the occurrence of the combined endpoint at 14.1%. 
Conclusions: Elevated RDW is associated with a worse outcome following AVR, independent of RBC. 
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INTRODUCTION
Red cell distribution width (RDW) is a parameter that reflects 
the variability of the size of red blood cells. It is calculated 
automatically or manually by dividing the standard deviation 
of red blood cell volume and the volume of red blood cells 
expressed as a percentage. RDW = (standard deviation of 
mean corpuscular volume [MCV] ÷ mean MCV) × 100. Until 
now RDW has been used mainly as an auxiliary marker in 
haematology indicating the increased destruction or impaired 
production of red blood cells. Several studies have reported 
that elevated RDW levels are associated with poor outcomes 
in patients with such cardiovascular diseases as coronary artery 
disease, idiopathic pulmonary hypertension, chronic heart 
failure (HF), and severe aortic stenosis after transcatheter 
aortic valve implantation [1–5]. Its prognostic utility in patients 
undergoing aortic valve replacement surgery is unknown. 
Therefore, we attempted to check the prognostic value of 
RDW in this group of patients.
METHODS
A prospective study was conducted on a group of 191 consecu-
tive patients with severe symptomatic aortic stenosis (a valve 
area below 1 cm2 and a mean pressure gradient ≥ 40 mm Hg), 
who were undergoing elective aortic valve replacement surgery 
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at the Institute of Cardiology, Warsaw, Poland. Exclusion criteria 
were: a lack of consent to participate in the study and age 
under 18 years. Patients with active neoplastic diseases, au-
toimmune diseases, and chronic inflammatory bowel diseases 
were excluded from the analyses. A preoperative complete 
blood count (a blood sample taken a day before surgery), data 
on risk factors, the course of operations, and the postoperative 
period were assessed. Full blood counts were measured from 
K2EDTA samples using a Sysmex K-4500 electronic counter. 
We also analysed the occurrence of the pre-defined prima-
ry composite endpoint in a 30-day follow-up, which consisted 
of death from all causes and such complications as: periopera-
tive myocardial infarction (defined as the development of new 
Q waves in two or more leads on an electrocardiogram or altera-
tions of myocardial contractility that did not previously exist in 
echocardiography), perioperative renal failure (requiring renal 
replacement therapy), prolonged mechanical ventilation (either 
mechanical ventilatory support lasting longer than 24 h or the 
need for reintubation), stroke (evidence of a new neurological 
deficit or transient ischaemic attack, confirmed by an imaging 
test), HF (defined as the need for a supply of catecholamines 
more than 48 h after leaving the cardiopulmonary bypass or 
the need to resupply), successfully resuscitated cardiac arrest, 
the occurrence of multiple-organ failure (dysfunction of two 
or more organs — based on laboratory parameters and/or the 
need to use organ replacement therapy), and the need for ad-
ditional surgery for any reason. The length of total hospitalisation 
and the length of the postoperative stay in the Intensive Care 
Unit were also recorded. The secondary endpoint was total 
mortality. The follow-up of discharged patients was conducted 
through telephone interviews and clinic visits. 
The protocol was approved by the Institutional Ethics 
Committee.
Statistical analysis
Statistical analysis was performed using SPSS software. Uni-
variate analysis followed by multivariate regression analysis 
was performed. Data are presented as medians with ranges 
if continuous, or as frequencies if categorical. Results were 
considered significant when p was less than 0.05. To assess the 
predictive ability of the RDW, receiver operating characteristic 
(ROC) curves analysis was used.
RESULTS
One hundred and ninety-one patients after aortic valve 
replacement surgery with or without other concomitant pro-
cedures were examined. In 124 patients a biological aortic 
valve prosthesis was implanted, and in 67 a mechanical valve. 
All procedures were performed through a midline sternotomy 
incision under general anaesthesia in mild systemic hypother-
mia (temperature 32–34°C).
Table 1 shows the preoperative characteristics of the pa-
tients studied. Ten (5.2%) patients had significantly impaired 
left ventricular systolic function (ejection fraction < 35%) 
(Table 1).
In the postoperative period, in the 30-day follow-up, 
death occurred in 10 patients (the first patient died suddenly 
— cause of death unknown, the second patient died because 
of early infective endocarditis, seven patients died as a result of 
gradually increasing multi-organ failure and the tenth patient 
died due to post-operative bleeding).
We observed the occurrence of the composite endpoint 
in 54 patients (perioperative renal failure in six patients, 
prolonged mechanical ventilation for 21 patients, stroke in 
three patients and HF in 45 patients). Seven patients were 
successfully resuscitated after cardiac arrest, and the occur-
Table 1. Baseline characteristics of the study population (n = 191)
Preoperative characteristics of patients Values
Age [years]* 66.2 ± 11.1
Male: men 111 (58.1%)
Previous myocardial infarction 18 (9.4%)
Coronary artery disease 81 (42.4%)
Stroke in history 5 (5.4%)
Atrial fibrillation 38 (19.9%)
Peripheral atherosclerosis 19 (9.9%)
Insulin dependent DM 7 (3.7%)
Hypertension 137 (77.7%)
Current smoker 64 (33.5%)
Hyperlipidaemia 84 (44%)
Body mass index [kg/m2]* 27.9 ± 4.2
Chronic obstructive airways disease 15 (7.8%)
Chronic kidney disease (GFR < 60) 50 (26.2%)
LVEF [%]* 59.7 ± 11.6
Pulmonary blood pressure [mm Hg]* 39.4 ± 14.1
NYHA classes* 2.4 ± 0.5
Haemoglobin [g/dL]* 13.5 ± 1.4
Haematocrit* 39.6 ± 3.7
Red blood cell count [mln/µL]* 4.4 ± 0.5
Platelets [1000/µL]* 187.7 ± 49.8
RDW [%]*
Mean corpuscular volume [fL]*
13.9 ± 0.7
90.1 ± 7.3
Creatinine [mmol/L]* 86.6 ± 22.3
Bilirubin [µmol/L]* 12.1 ± 9.5
Concomitant CABG 48 (25%)
Concomitant aortic surgery 24 (12.5%)
EuroSCORE II* 2.8 ± 2.1
Values are expressed as mean ± standard deviation* or number (%) 
of patients; CABG — coronary artery bypass grafting; DM — diabetes 
mellitus; GFR — glomerular filtration rate, LVEF — left ventricular ejec-
tion fraction; NYHA — New York Heart Association; RDW — red blood 
cell distribution width
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rence of multi-organ failure was observed in 16 patients. Re-
thoracotomy was performed in 20 patients, myocardial in-
farction occurred in 11 patients. In univariate analysis RDW 
(p < 0.0001), haemoglobin level (p = 0.005), haematocrit 
(p = 0.01), red blood cell count (RBC; p = 0.002), glomerular 
filtration rate (p = 0.003), New York Heart Association clas-
sification (p = 0.02), atrial fibrillation (p = 0.0044), and pul-
monary blood pressure (p = 0.004) were associated with the 
occurrence of the composite endpoint at 30-day follow-up. 
RDW (p = 0.0005), haemoglobin level (p = 0.004), haema-
tocrit (p = 0.004), RBC (p = 0.0009), and mean corpuscular 
volume (p = 0.01) were associated with an increased risk 
of death. In multivariate analysis, RDW (OR 3.274; 95% CI 
1.285–8.344; p = 0.0003) and RBC (OR 0.373; 95% CI 
0.176–0.787; p = 0.0097) remained independent predictors 
of the composite endpoint. Tables 2 and 3 show the analysis 
of the predictors of mortality and the composite endpoint.
The real mortality was 5.2 vs. 2.8 expected mortality 
calculated using EuroSCORE II.
Receiver operating characteristic analysis determined the 
cut-off value of RDW for the prediction of the occurrence of 
the composite endpoint at 14.1% (area under curve = 0.7, 
p = 0.008). Figure 1 depicts Kaplan-Meier event-free survival 
curves for composite endpoint according to the cut-off value 
of RDW. 
DISCUSSION
To our knowledge, this is the first report showing the prognostic 
significance of RDW in predicting complications in patients 
undergoing aortic valve replacement surgery because of severe 
stenosis at the 30-day follow-up. RDW is a parameter measured 
during routine complete blood counts. It carries none of the ex-
tra costs and risks associated with the performance of additional 
diagnostics (which are often invasive). Previous studies have 
indicated higher values of RDW as an applicable parameter in 
Table 2. Analysis of predictive factors for the occurrence of death
Variable Univariable Multivariable
Odds ratio 95% Cl P Odds ratio 95% Cl P
RDW 2.821 1.574–5.056 0.0005 3.702 1.904–7.196 0.0001
Haemoglobin 0.505 0.315–0.810 0.004
Haematocrit 0.786 0.668–0.926 0.004
RBC 0.085 0.020–0.362 0.0009
MCV 1.219 1.042–1.426 0.01
CI — confidence interval; MCV — mean corpuscular volume; RBC — red blood cell count; RDW — red blood cell distribution width
Table 3. Analysis of composite endpoint for the occurrence of predictive factors
Variable Univariable Multivariable
Odds ratio 95% Cl P Odds ratio 95% Cl P
RDW 2.540 1.638–3.939 < 0.0001 3.274 1.285–8.344 0.0003
Haemoglobin 0.711 0.561–0.902 0.005
Haematocrit 0.895 0.822–0.975 0.01
RBC 0.330 0.162–0.672 0.002 0.373 0.176–0.787 0.0097
Glomerular filtration rate 0.970 0.951–0.990 0.003
NYHA classes 2.077 1.117–3.861 0.02
Atrial fibrillation 2.925 1.398–6.120 0.004
Pulmonary blood pressure 1.052 1.016–1.089 0.004
CI — confidence interval; NYHA — New York Heart Association; RBC — red blood cell count; RDW — red blood cell distribution width
Figure 1. Kaplan–Meier event-free survival curves following 
aortic valve replacement surgery, for composite endpoint accor-
ding to the cut-off value of red cell distribution width (RDW)
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reserves are lowered. Some authors suggest that RDW is an 
indicator of a patient’s physiologic reserve — the ability of 
cells to defend against the strong stress of hypoxia [25–27]. 
The reserve is very important in such stressful situations as 
surgical intervention. It can explain the higher incidence of 
complications in patients with elevated RDW. 
We still do not know whether elevated RDW is an in-
dependent cardiovascular risk factor or a marker of inflam-
matory reaction or oxidative stress. Nevertheless, the role of 
RDW as a predictor of mortality in different groups of patients 
has been widely described. RDW has also been included as 
a key element of the scales based on complete blood counts 
assessing the risks of mortality and morbidity [28, 29]. There-
fore, on the basis of this work, it appears that RDW may be 
helpful in selecting a group of patients with a higher risk for 
postoperative complications requiring additional attention in 
being qualified for surgery.
Limitations of the study
This study has some potential limitations. It was a single-cen-
tred study that included a limited number of participating 
patients. Further studies are needed to explain the patho-
mechanisms linking an increased risk for complications in 
patients with higher values of the RDW.
CONCLUSIONS
Without fully understanding the mechanisms linking a higher 
risk for complications and a tendency towards increased 
mortality in patients with anisocytosis, it seems to be too 
early to name RDW as a simple and widely available prog-
nostic predictor in patients undergoing isolated aortic valve 
replacement surgery. Further investigation is required, and 
information about RDW’s prognostic value may provide an 
additional clue for physicians in identifying patients who will 
not benefit from surgical treatment of aortic stenosis or may 
be eligible for other types of therapy.
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Podwyższona wartość rozpiętości rozkładu 
objętości erytrocytów jako marker rokowniczy 
u pacjentów poddawanych operacji wymiany 
zastawki aortalnej
Piotr Duchnowski1, Piotr Szymański1, Ewa Orłowska-Baranowska1, Mariusz Kuśmierczyk2,  
Tomasz Hryniewiecki1
1Klinika Wad Nabytych Serca, Instytut Kardiologii, Warszawa
2Klinika Kardiochirurgii i Transplantologii, Instytut Kardiologii, Warszawa
S t r e s z c z e n i e
Wstęp: W dotychczasowych badaniach wykazano, że podwyższone wartości rozkładu objętości erytrocytów (RDW) są 
związane z gorszym rokowaniem u osób z chorobą wieńcową, niewydolnością serca czy ciężką stenozą aortalną leczoną 
przezcewnikowym wszczepieniem zastawki aortalnej. Znaczenie RDW u pacjentów poddawanych operacji chirurgicznej 
wymiany zastawki aortalnej jest nieznane.
Cel: Celem niniejszej pracy była ocena wartości prognostycznej RDW u chorych poddawanych operacyjnemu leczeniu 
ciężkiej stenozy aortalnej.
Metody: Prospektywne badanie przeprowadzono w grupie kolejnych 191 pacjentów z ciężką objawową stenozą aortalną 
poddawanych operacyjnemu leczeniu wymiany zastawki aortalnej. Na z góry zdefiniowany pierwszorzędowy złożony punkt 
końcowy w obserwacji 30-dniowej składało się wystąpienie następujących powikłań: zgonu z wszystkich przyczyn, okołoza-
biegowego zawału serca, okołooperacyjnej niewydolności nerek, przedłużonej wentylacji mechanicznej, udaru ośrodkowego 
układu nerwowego, skutecznie resuscytowanego zatrzymania akcji serca, niewydolności wielonarządowej i konieczności 
reoperacji z jakiejkolwiek przyczyny. Drugorzędowym punktem końcowym była śmiertelność.
Wyniki: Pierwszorzędowy złożony punkt końcowy w obserwacji 30-dniowej zaobserwowano u 54 pacjentów. W analizie 
jednoczynnikowej predyktorami wystąpienia pierwszorzędowego punktu końcowego były: RDW (p < 0,0001), hemoglobina 
(p = 0,005), hematokryt (p = 0,01), liczba erytrocytów (p = 0,002), wskaźnik przesączania kłębuszkowego (p = 0,003), 
stopień niewydolności serca wg klasyfikacji NYHA (p = 0,02), migotanie przedsionków (p = 0,0044) i ciśnienie w tętnicy 
płucnej (p = 0,004). Wartości RDW (p = 0,0005), hemoglobiny (p = 0,004), hematokrytu (p = 0,004), liczba erytrocytów 
(p = 0,0009) i średnia objętość erytrocytów (p = 0.01) wiązały się ze zwiększonym ryzykiem wystąpienia zgonu. Analiza 
wieloczynnikowa potwierdziła znaczenie RDW (OR 3.274; 95% Cl 1,285–8,344; p = 0,0003) jako niezależnego predyktora 
wystąpienia pierwszorzędowego złożonego punktu końcowego. Przy użyciu statystyki krzywej ROC wyznaczono punkt odcięcia 
RDW dla wystąpienia złożonego punktu końcowego na poziomie 14,1% (pole pod krzywą 0,07; p = 0,008).
Wnioski: Wyższe wartości RDW są związane z gorszym rokowaniem u pacjentów poddawanych operacji wymiany zastawki 
aortalnej, niezależnie od liczby erytrocytów.
Słowa kluczowe: stenoza aortalna, operacja zastawki, markery stanu zapalnego, ocena ryzyka, rozpiętość rozkładu objętości 
erytrocytów
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